Pfizer discards one weight loss medication in ethnicity to conceive Ozempic adversary
June 27, 2023: On Monday, Pfizer stated that it would quit producing its observed obesity and diabetes medication, lotiglipron, because ...
June 27, 2023: On Monday, Pfizer stated that it would quit producing its observed obesity and diabetes medication, lotiglipron, because ...